ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

PLUR vs ATYR // EV/EBITDA & P/E VALUATION

Pluri Inc. (NASDAQ) VS. aTyr Pharma Inc. (NASDAQ) • 15-METRIC TALLY: PLUR 3 — ATYR 1
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PLUR VS. ATYR) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC PLUR ATYR SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 49.00% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE — — — TIE /valuation <GO>
Free Cash Flow Yield — — — TIE /fcf-yield <GO>
Operating Margin -60.00% -60.00% 0.00 TIE /operating-margins <GO>
Net Profit Margin -60.00% -60.00% 0.00 TIE /net-margins <GO>
Revenue Growth (YoY) 180.00% -19.10% +199.10 PLUR /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 3/9 2/9 +1.00 PLUR /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 61.7 97.3 -35.59 ATYR /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $16.1M $13.5M $2.6M PLUR /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR PLUR REV ATYR REV PLUR GROSS % ATYR GROSS % PLUR FCF ATYR FCF
FY 2025 $1.3M $190.0K 49.0% — -$19.8M -$62.1M
FY 2024 $326.0K $235.0K 98.0% — -$18.3M -$69.2M
FY 2023 $287.0K $353.0K — — -$22.9M -$33.2M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PLUR // BETA —
ATYR // BETA —